These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9383900)

  • 1. Current problems of regulation of allergenic extracts in Germany.
    Haustein D
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):123-6. PubMed ID: 9383900
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural allergen extracts: is there a future in allergy diagnosis and therapy?
    Lehrer SB; Reese G
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):73-8; discussion 79. PubMed ID: 9383893
    [No Abstract]   [Full Text] [Related]  

  • 3. Allergenic products standardization--the role of major allergens.
    Helm RM; Burks AW
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):164-73. PubMed ID: 9383906
    [No Abstract]   [Full Text] [Related]  

  • 4. Potency determination of allergenic extracts using mediator release of rat basophil leukemia cells.
    Hoffmann A; Vogel L; Scheurer S; Vieths S; Haustein D
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):203-8. PubMed ID: 9383911
    [No Abstract]   [Full Text] [Related]  

  • 5. Standardisation of allergens in Europe.
    Sjöholm I
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):107-10. PubMed ID: 9383897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization of allergen extracts for immunotherapy: where do we stand?
    Becker WM; Vogel L; Vieths S
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):470-5. PubMed ID: 17088654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standards for practical allergen-specific immunotherapy.
    Alvarez-Cuesta E; Bousquet J; Canonica GW; Durham SR; Malling HJ; Valovirta E;
    Allergy; 2006; 61 Suppl 82():1-20. PubMed ID: 16930249
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation, role and future of named patient products in Germany.
    May S; Kaul S; Lüttkopf D; Vieths S
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():193-7; discussion 197-9. PubMed ID: 20799461
    [No Abstract]   [Full Text] [Related]  

  • 9. Skin prick testing in biological standardization of allergenic products.
    Malling HJ
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):157-63. PubMed ID: 9383905
    [No Abstract]   [Full Text] [Related]  

  • 10. The expectations of the medical profession concerning the EEC directives for allergenic extracts.
    Fuchs E
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1992; (85):19-22; discussion 22-3. PubMed ID: 1540292
    [No Abstract]   [Full Text] [Related]  

  • 11. Standardization of allergen extracts.
    Matthiesen F
    Z Hautkr; 1988; 63 Suppl 4():52-4. PubMed ID: 3252626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant allergens; basic and practical considerations.
    Breiteneder H; Hoffmann-Sommergruber K; Vanek-Krebitz M; Kraft D; Scheiner O
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):80-6. PubMed ID: 9383894
    [No Abstract]   [Full Text] [Related]  

  • 13. Proposals for harmonization of allergens regulation in the European Union.
    Timón M
    Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():1-3. PubMed ID: 29108764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory control and standardization of allergenic extracts.
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1988; (82):177-220. PubMed ID: 3196018
    [No Abstract]   [Full Text] [Related]  

  • 15. Allergen immunotherapy and standardization and stability of allergen extracts.
    Weber RW
    J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 2):1093-6. PubMed ID: 2600347
    [No Abstract]   [Full Text] [Related]  

  • 16. New regulatory documents and procedures. I: Guideline on clinical trials of SIT products, European Pharmacopoeia, and note for guidance on allergen products.
    Pini C
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():187-90; discussion 191-2. PubMed ID: 20799460
    [No Abstract]   [Full Text] [Related]  

  • 17. Principles and practice in the monograph on allergenic extracts of the European Pharmacopoeia.
    Stevens E
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):120-2. PubMed ID: 9383899
    [No Abstract]   [Full Text] [Related]  

  • 18. The expectations of the European Allergen Manufacturers Group concerning the EEC directives for allergen extracts.
    Williams GD
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1992; (85):7-17. PubMed ID: 1540299
    [No Abstract]   [Full Text] [Related]  

  • 19. Anaphylactic reactions during immunotherapy.
    Rezvani M; Bernstein DI
    Immunol Allergy Clin North Am; 2007 May; 27(2):295-307, viii. PubMed ID: 17493504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of allergen products in Europe: what now?--where next?
    Rooke MB
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):138-44. PubMed ID: 9383903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.